Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 56 Carcinoma, Non-Small-Cell Lung 56 Carcinoma, Renal Cell 34 Neoplasms 33 Neoplasm Metastasis 29 Colorectal Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 22 Pancreatic Neoplasms 22 Carcinoma, Hepatocellular 21 Carcinoma, Transitional Cell 18 Lung Neoplasms 17 Glioblastoma 15 Ovarian Neoplasms 14 Triple Negative Breast Neoplasms 13 Breast Neoplasms 13 Urinary Bladder Neoplasms 11 Stomach Neoplasms 11 Head and Neck Neoplasms 10 Uveal Melanoma 9 Recurrence 8 Myelodysplastic Syndromes 8 Lymphoma 8 Leukemia, Myeloid, Acute 8 Advanced Cancer 8 Small Cell Lung Carcinoma 7 Multiple Myeloma 7 Kidney Neoplasms 7 Hodgkin Disease 7 Hematologic Neoplasms 7 Glioma 7

Interventions

pembrolizumab 3 Cyclophosphamide 3 fludarabine 2 Rosuvastatin Calcium 2 Radiotherapy 2 Paclitaxel 2 Ipilimumab 2 Interleukin-2 2 Carboplatin 2 spartalizumab 1 peposertib 1 osimertinib 1 niraparib 1 neotil 1 necitumumab 1 mirdametinib 1 apatinib 1 amivantamab 1 Valganciclovir 1 Tomography, X-Ray Computed 1 Rifampin 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Midazolam 1 Metformin 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumor, Adult × Nivolumab × Clear all

NCT03728179 2024-02-20

RACIN

Centre Hospitalier Universitaire Vaudois

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡